Trial intelligence / Profile preview

Dexmedetomidine for Pain in CABG

NCT05534230Unknown

Sponsor
Wayne State University
Start
Sep 2022
Primary completion
Jul 2023
Modality
Small Molecules
01

Overview

Randomised trial of dexmedetomidine in pain (2 arms), sponsored by Wayne State University. Primary endpoints: Visual analog pain (VAS) scores at 24 hours and Total opioid consumption in the first 24 hours after surgery. Status: unknown.

02

Drugs

dexmedetomidine
03

Conditions

pain

Beyond the preview

Go deeper on NCT05534230.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05534230.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call